Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma - Concepedia

Concepedia

Publication | Open Access

Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

DOI Full Paper Access

256

Citations

23

References

2009

Year

Thomas E. Witzig, Peter H. Wiernik, Timothy D. Moore, Craig B. Reeder, Craig E. Cole, Glen R. Justice, Henry G. Kaplan, Michael Voralia, Dennis Pietronigro, Kenichi Takeshita,

Journal of Clinical Oncology

Abstract

Oral lenalidomide monotherapy produces durable responses with manageable adverse events in patients with relapsed/refractory indolent NHL, warranting further investigation of treatment for indolent NHL.

References

	Year	Citations

Page 1